These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1974722)

  • 1. Pharmacologic evidence for nociception resulting from noncontingent "rewarding" brain stimulation.
    Pollock J; Kornetsky C
    Physiol Behav; 1990 Apr; 47(4):761-5. PubMed ID: 1974722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the supraspinal analgesic activity and abuse liability of ethylketocyclazocine.
    Unterwald E; Sasson S; Kornetsky C
    Eur J Pharmacol; 1987 Jan; 133(3):275-81. PubMed ID: 3030776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu and kappa opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion.
    Carr KD; Bonnet KA; Simon EJ
    Brain Res; 1982 Aug; 245(2):389-93. PubMed ID: 6289969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam's impact on self-stimulation but not stimulation-escape suggests hedonic modulation.
    Carden SE; Coons EE
    Behav Neurosci; 1990 Feb; 104(1):56-61. PubMed ID: 2317286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected opioids and responding for intracranial reinforcement.
    Reid LD; Hubbell CL; Dunn LL; Hunter GA; Costa T
    Neuropeptides; 1985 Feb; 5(4-6):331-4. PubMed ID: 3889692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of atropine, procaine and dopamine in the rat ventral tegmentum on lateral hypothalamic rewarding brain stimulation.
    Kofman O; McGlynn SM; Olmstead MC; Yeomans JS
    Behav Brain Res; 1990 Apr; 38(1):55-68. PubMed ID: 2346616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative effects of ethylketazocine in the rat: stereospecificity and antagonism by naloxone.
    Herling S; Shannon HE
    Life Sci; 1982 Nov 15-22; 31(20-21):2371-4. PubMed ID: 6131363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic differences in opioids binding sites and in antinociceptive activities of morphine and ethylketocyclazocine.
    Jacob J; Michaud G; Nicola MA; Prudhomme N
    Life Sci; 1983; 33 Suppl 1():645-8. PubMed ID: 6141504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic effects of ethylketocyclazocine and morphine in rat and toad.
    Carr KD; Aleman DO; Holland MJ; Simon EJ
    Life Sci; 1984 Aug; 35(9):997-1003. PubMed ID: 6433131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary kappa hyperalgesic mechanisms II. The effects of ethylketazocine administered into the fourth cerebral ventricle of the conscious dog.
    Kamerling SG; Martin WR; Wu KM; Wettstein JG
    Life Sci; 1983 Oct; 33(18):1839-43. PubMed ID: 6139723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the effects of amphetamine on brain self-stimulation behavior.
    Schaefer GJ; Michael RP
    Behav Brain Res; 1988 Jul; 29(1-2):93-101. PubMed ID: 3261172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal by naloxone of spinal antinociceptive effects of fentanyl, ketocyclazocine and midazolam.
    Serrao JM; Goodchild CS; Gent JP
    Eur J Anaesthesiol; 1991 Sep; 8(5):401-6. PubMed ID: 1657598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripelennamine: enhancement of brain-stimulation reward.
    Unterwald EM; Kucharski LT; Williams JE; Kornetsky C
    Life Sci; 1984 Jan; 34(2):149-53. PubMed ID: 6607395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests.
    Turkish S; Cooper SJ
    Pharmacol Biochem Behav; 1984 Jul; 21(1):47-51. PubMed ID: 6087378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral and central antinociceptive actions of ethylketocyclazocine in the formalin test.
    Abbott FV
    Eur J Pharmacol; 1988 Jul; 152(1-2):93-100. PubMed ID: 2905269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.